この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2016/1/221 分で読めます
Postmarket Management of Cybersecurity in Medical Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance entitled "Postmarket Management of Cybersecurity in Medical Devices." This draft guidance informs industry and FDA staff of the Agency's recommendations for identifying, addressing, and monitoring cybersecurity vulnerabilities and exploits for postmarket management of medical devices. This draft guidance is neither final nor is it in effect at this time.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →